G01N 2800/2857
Seizure disorders
Official title: Seizure disorders; Epilepsy
G01N2800/2857 (Seizure disorders) appears on 50 US grants and 115 published applications in this corpus.
Search patents in G01N- Granted patents
- 50
- Published applications
- 115
- Assignees
- 78
- Inventors
- 213
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 2 |
| 2006 | 1 | 5 |
| 2007 | 2 | 8 |
| 2008 | 0 | 3 |
| 2009 | 0 | 6 |
| 2010 | 4 | 15 |
| 2011 | 5 | 1 |
| 2012 | 2 | 3 |
| 2013 | 3 | 6 |
| 2014 | 2 | 5 |
| 2015 | 2 | 8 |
| 2016 | 2 | 3 |
| 2017 | 2 | 9 |
| 2018 | 2 | 7 |
| 2019 | 3 | 1 |
| 2020 | 3 | 5 |
| 2021 | 4 | 6 |
| 2022 | 0 | 7 |
| 2023 | 4 | 5 |
| 2024 | 4 | 6 |
| 2025 | 4 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Composition for diagnosis or treatment of a condition associated with increased activity of EIF4E comprising an EIF4E inhibitor10 Mar 2026US 12,570,975 B2SoVarGen Co., Ltd.
- Biomarkers and methods for evaluation and treatment of epileptic vs non-epileptic seizures / no seizures / psychogenic non-epileptic seizures16 Dec 2025US 12,498,384 B2Cognizance Biomarkers, LLC
- Composition for prevention or treatment of intractable epilepsy comprising mTOR inhibitor28 Oct 2025US 12,453,733 B2SoVarGen Co., Ltd.
- Ganglioglioma-induced animal model and a method for diagnosing and treating ganglioglioma and related diseases22 Jul 2025US 12,364,776 B2Korea Advanced Institute of Science and Technology
- Methods of selecting subjects for treatment with metabolomic modulators6 May 2025US 12,292,445 B2The Regents of the University of California
- Methods and systems for identifying or treating central nervous systems disease21 Aug 2025US 2025/0263488 A1Arialys Therapeutics, Inc.
- Method for prediction of mortality, functional outcome and recovery after status epilepticus7 Nov 2024US 2024/0371526 A1Assistance Publique-Hopitaux de Paris
- Immobilized protein system for rapid and enhanced multiplexed diagnostics31 Oct 2024US 2024/0361340 A1Cornell University
- Biomarkers and methods for detection of seizures and epilepsy9 May 2024US 2024/0151733 A1Cognizance Biomarkers, LLC
- Use of the emm antigen as a biomarker of inherited gpi deficiencies28 Mar 2024US 2024/0103019 A1Assistance Publique-Hopitaux de Paris
Most cited
By later US patents
- System for seizure suppression90US 7,892,764 B2Legacy Emanuel Hospital & Health Center · 2011
- Method for diagnosing a pervasive developmental disorder7US 7,709,213 B22010
- Immobilized protein system for rapid and enhanced multiplexed diagnostics6US 9,547,014 B2Cornell University · 2017
- Diagnostic markers for multiple epilepsy phenotypes5US 7,262,290 B2The Trustees of the University of Pennsylvania · 2007
- Diagnostic methods for determining susceptibility to convulsive conditions4US 7,153,692 B2Queen's University at Kingston · 2006